1. 2022-RA-1009-ESGO Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Johanna; Mirza, Mansoor R.; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Vener... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1144-ESGO Management of immune-related adverse events in patients with solid tumours treated with dostarlimab in the GARNET study. (20th October 2022) Authors: Berton, Dominique; Andre, Thierry; Oaknin, Ana; Moreno, Victor; Trigo, José; Curigliano, Giuseppe; Tinker, Anna V; Boni, Valentina; Barretina-Ginesta, Maria Pillar; Pikiel, Joanna; Pothuri, Bhavana; Mirza, Mansoor R; Panovcova, Petra; Duan, Tao; Dabrowski, Christine; Dabrowski, Christine; Zografo... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-1194-ESGO Efficacy of dostarlimab in endometrial cancer by molecular subtype: a post hoc analysis of the GARNET study. (20th October 2022) Authors: Tinker, Anna V; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Mirza, Mansoor R; Duan, Tao; Han, Xinwei; Zildjian, Sybil; Zografos, Elefthe... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2022-RA-1297-ESGO A subgroup analysis of response rate by patient characteristics in patients with endometrial cancer receiving monotherapy dostarlimab in the GARNET trial. (20th October 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David M; Kristeleit, Rebecca; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan E; Pikiel, Joanna; Miza, Mansoor R; Duan, Tao; Dong, Yuping; Zografos, Elefth... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2022-RA-588-ESGO Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients with advanced solid tumours: ARTISTRY-1. (20th October 2022) Authors: Vaishampayan, Ulka; Tomczak, Piotr; Muzaffar, Jameel; Winer, Ira; Rosen, Seth D; Hoimes, Christopher J; Chauhan, Aman; Spreafico, Anna; Lewis, Karl D; Bruno, Debora S; Dumas, Olivier; McDermott, David F; Strauss, James F; Chu, Quincy Siu-Chung; Gilbert, Lucy; Chaudhry, Arvind; Rege, Jessicca; Bon... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022-RA-945-ESGO Antitumour activity of dostarlimab by PD-L1 and tumour mutation burden in patients with mismatch repair deficient and proficient tumours in the GARNET trial. (20th October 2022) Authors: Banerjee, Susana; André, Thierry; Berton, Dominique; Ellard, Susan L; Jimenez, Begoña; Samouëlian, Vanessa; Gilbert, Lucy; Boni, Valentina; Han, Xinwei; Antony, Grace; Veneris, Jennifer; Oaknin, Ana Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 291 Phase Ib study of selicrelumab (CD40 agonist) in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors. (9th November 2020) Authors: Barlesi, Fabrice; Lolkema, Martijn; Rohrberg, Kristoffer Staal; Hierro, Cinta; Marabelle, Aurelien; Razak, Albiruni Abdul; Teixeira, Luis; Boni, Valentina; Miller, Wilson H; Aggarwal, Charu; Stern, Martin; Cirovic, Olivera; Cirovic, Olivera; Romagnoli, Barbara; Christen, Randolph; Dodia, Raksha; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial. (10th December 2020) Authors: Winer, Ira; Gilbert, Lucy; Vaishampayan, Ulka; Rosen, Seth; Hoimes, Christopher; Muzaffar, Jameel; Spreafico, Anna; McDermott, David; Chu, Quincy; Dumas, Olivier; Chauhan, Aman; Chaudhry, Arvind; Tomczak, Piotr; Boni, Valentina; Bruno, Debora; Curtis, Kelly; Wang, Yan; Dorn, Elizabeth; Rege, Jess... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 385 Safety and antitumor activity of dostarlimab in patients (PTS) with advanced or recurrent DNA mismatch repair deficient (DMMR) or proficient (MMRP) endometrial cancer (EC): results from the garnet study. (4th December 2020) Authors: Oaknin, Ana; Gilbert, Lucy; Tinker, Anna V; Sabatier, Renaud; Boni, Valentina; O'malley, David M; Ghamande, Sharad; Guo, Wei; Im, Ellie; Pothuri, Bhavana Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 39/#452 Immune-related endpoints in patients with advanced or recurrent endometrial cancer treated with dostarlimab in the garnet study. (4th December 2022) Authors: Oaknin, Ana; Pothuri, Bhavana; Gilbert, Lucy; Sabatier, Renaud; Brown, Jubilee; Ghamande, Sharad; Mathews, Cara; O'Malley, David; Boni, Valentina; Gravina, Adriano; Banerjee, Susana; Miller, Rowan; Pikiel, Joanna; Mirza, Mansoor; Duan, Tao; Zildjian, Sybil; Zografos, Eleftherios; Veneris, Jennife... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗